A

Amgen

Makes biotech medicines for serious illnesses

Director Commercial Analytics - Obesity

Business OperationsConfirmed live in the last 24 hours
Full-timeHyderabad, Telangana, IndiaNo salary listedIn-person

About the Job

Requirements

  • A doctorate degree, a master's degree, or a bachelor's degree with 18 or more years of relevant experience is required.
  • Substantial experience in commercial analytics, strategic insights, consulting, or related functions within pharmaceuticals, biotechnology, healthcare, or life sciences is preferred.
  • Depth across product and brand strategy, launch analytics, sales force effectiveness, HCP and account analytics, payer and pricing analysis, commercial measurement, and executive insight translation is preferred.
  • Experience supporting U.S. or global launches and growth assets in competitive, rapidly evolving therapeutic categories, ideally with high access and execution complexity, is preferred.
  • Strong understanding of U.S. pharmaceutical commercialization, selling models, field execution, stakeholder prioritization, and healthcare ecosystem dynamics is preferred.
  • Knowledge of U.S. healthcare data ecosystems used for commercial decision-making, including sales, field activity, promotional engagement, claims, payer and pricing, and access-related data, is preferred.
  • Proven ability to translate complex analysis into recommendations that influence senior stakeholders and action planning is preferred.
  • Experience partnering with technology, data science, and data engineering teams to develop scalable analytics products is preferred.
  • Strong executive communication, stakeholder management, strategic thinking, and ability to balance practical delivery with high-quality analytical standards in a global environment are preferred.

Responsibilities

  • Set the commercial analytics agenda for obesity, including the roadmap, delivery priorities, and senior decision forums.
  • Turn product, field, account, payer and pricing, and U.S. stakeholder questions into pragmatic analytical plans and usable decision assets.
  • Manage intake, prioritization, quality, governance, and execution without unnecessary process burden.
  • Surface risks, options, and trade-offs early, supported by evidence and grounded in commercial reality.
  • Raise standards for reusable methods, evolve how the function works, and build capabilities that improve over time as business needs change.
  • Shape analysis that informs product strategy, commercialization readiness, lifecycle planning, and in-market action.
  • Track the competitive landscape, treatment environment, access and pricing shifts, HCP behavior, and external signals, with strong attention to U.S. dynamics.
  • Synthesize market, customer, competitive, and policy insights into assessments of launch readiness.
  • Synthesize internal and external data to identify opportunities, risks, and strategic priorities, and convert them into executive-ready narratives that clarify implications and decisions.
  • Lead analysis for field sizing, customer segmentation, HCP and account engagement, and field execution.
  • Develop national and sub-national insights that guide resource allocation, launch sequencing, and customer prioritization.
  • Work across commercial, medical, market access, and product teams to evaluate strategic options and inform planning.
  • Advance patient journey, market landscape, and stakeholder insights to inform priorities.
  • Develop executive-ready insights that anticipate risks, highlight opportunities, and enable confident choices.
  • Develop predictive models, scenario simulations, segmentation approaches, and driver analyses to answer high-value business questions.
  • Apply quantitative techniques to estimate demand, assess adoption drivers, and evaluate the impact of market and competitive changes.
  • Industrialize analytical methods through scalable, governed, and reusable solutions in partnership with data science and technology teams.
  • Establish analytical standards, validation practices, and documentation that improve consistency, transparency, and confidence in outputs.
  • Expand the use of automation, artificial intelligence, and experimentation to accelerate delivery and increase analytical rigor.
  • Own the commercial analytics operating model for domain intake, prioritization, standards, delivery cadence, quality, and adoption.
  • Standardize recurring work into reusable insight products, tools, and methods where scale creates value.
  • Clarify how the function partners with forecasting, primary market research, and technology colleagues to deliver integrated work.
  • Improve speed, consistency, and impact through pragmatic reuse, automation, and fit-for-purpose solutions.
  • Build a connected capability recognized by the global obesity business for judgment, reliability, and business partnership.
  • Build, develop, and lead a high-performing India-based team of analytics professionals.
  • Create an environment of analytical excellence, accountability, curiosity, continuous learning, and ownership.
  • Coach future leaders by expanding their commercial judgment, technical depth, strategic thinking, executive communication, and ability to influence across a global organization.
  • Set clear goals, performance expectations, and development paths that link individual growth to organizational priorities.
  • Help the team understand the business behind the analysis while creating an environment where curiosity, ownership, and continuous learning are expected and rewarded.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs